Berry Genomics
Beijing
About Berry Genomics
Berry Genomics is the genomics company specializing in developing and commercializing technologies for life sciences and clinical applications. Among the clinical applications, the company is dedicated to developing next generation sequencing (NGS) based tests for genetic disease and cancer from preconception to adulthood.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $155.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2020)
- Ticker: szse:000710
- Website: berrygenomics.com
- Phone: 010 5325 9188
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/berry-genomics-196446 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.